Under the terms and conditions of the rights issue, each existing share in Haldex entitles to one (1) subscription right and one (1) subscription right entitles to subscription for one (1) new share. The subscription price is SEK 23 per share, which means that the rights issue will raise a maximum of SEK 504 m, before issue costs, through the issuance of not more than 21,919,750 new shares. The record date at Euroclear Sweden AB for participation in the rights issue with preferential rights is November 27, 2009. Subscription for new shares shall take place during the period from December 1, 2009 up to and including December 16, 2009. Timetable for the rights issue November 25, 2009 First day of trading in the share excluding right to participate in the rights issue November 27, 2009 Record date, i.e. shareholders who are registered in the share register on this day will receive subscription rights for participation in the rights issue November 27, 2009 Estimated day for publication of the prospectus December 1-11, 2009 Trading in subscription rights December 1-16, 2009 Subscription period Subscription undertakings and underwriting guarantees A number of Haldex’s largest shareholders, including Investment AB Öresund, ODIN Fonder, AFA, Göran Carlson through wholly- and part-owned companies, the Second AP Fund, the Fourth AP Fund and Apoteket’s Pension Foundation, collectively representing approximately 38.9 percent of the total number of shares and votes, 1) have expressed their support for the rights issue and have committed to subscribe for shares corresponding to their respective pro rata shares of the issue. In addition, a number of shareholders, including Investment AB Öresund, ODIN Fonder, the Fourth AP Fund and Apoteket’s Pension Foundation, have guaranteed to subscribe for additional shares corresponding to approximately 61.1 percent of the rights issue. Together, the above mentioned shareholders have thus committed and guaranteed, respectively, to subscribe for shares corresponding to 100 percent of the rights issue. 1) Excluding Haldex’s treasury shares. IMPORTANT NOTICE In certain jurisdictions, the publication or distribution of this press release may be subject to legal restrictions and persons in those jurisdictions where this press release has been published or distributed should inform themselves about and abide by such legal restrictions. This press release is not directed at persons located in the United States, Canada, Australia, Hong Kong, Japan or in any other country where the offer or sale of the subscription rights, interim shares or new shares is not permitted. This press release may not be published or distributed, directly or indirectly, in or into the United States, Canada, Australia, Hong Kong, Japan or any other country where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, other offer documentation, registrations or other actions in addition to what follows from Swedish law. Nor may the information in this press release be forwarded, reproduced or disclosed in such a manner that contravenes such restrictions or would require such additional prospectuses, other offer documentation, registrations or other actions. Failure to comply with this instruction may result in a violation of the United States Securities Act of 1933, as amended (the “Securities Act”) or laws applicable in other jurisdictions. This press release does not contain or constitute an invitation or an offer to acquire, sell, subscribe for or otherwise trade in shares, subscription rights or other securities in Haldex AB (publ). Any invitation to the persons concerned to subscribe for shares in Haldex AB will only be made through the prospectus that Haldex AB intends to publish in the beginning of September 2009, which prospectus will contain, among other things, financial statements as well as detailed information regarding Haldex AB’s Board of Directors and Management. No subscription rights, BTAs (interim shares) or new shares will be registered under the Securities Act or any provincial act in Canada and may not be transferred or offered for sale in the United States or Canada or to persons resident in Canada or on account of such persons other than pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act or in such exempt cases that do not require registration in accordance with any provincial act in Canada, respectively.